H.R. 2820 · 114th Congress
Stem Cell Therapeutic and Research Reauthorization Act of 2015
Law · 114-104 · Dec 18, 2015Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
22 cosponsors · 8 D, 14 R
3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- House Introduced Jun 18, 2015
- House Passed Sep 8, 2015
- Senate Passed Dec 9, 2015
- House Changes resolved Dec 16, 2015 421–0
- President To the President Dec 18, 2015
- President Signed Dec 18, 2015
- Law Dec 18, 2015
Stem Cell Therapeutic and Research Reauthorization Act of 2015
What it does: CRS summary · Public Law · Dec 18, 2015
(This measure has not been amended since it was reported to the Senate on December 3, 2015. The summary of that version is repeated here.)
Stem Cell Therapeutic and Research Reauthorization Act of 2015
(Sec. 2) This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)
The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program.
(Sec. 3) Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised.
(Sec. 4) HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
Votes to become law
About this bill and sources
Official title: Stem Cell Therapeutic and Research Reauthorization Act of 2015
Latest action (Dec 18, 2015): Became Public Law No: 114-104.
Policy area: Health · Origin: House · Introduced: Jun 18, 2015
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML) · Embed in your story
- House Introduced Jun 18, 2015
- House Passed Sep 8, 2015
- Senate Passed Dec 9, 2015
- House Changes resolved Dec 16, 2015 421–0
- President To the President Dec 18, 2015
- President Signed Dec 18, 2015
- Law Dec 18, 2015
Final vote · House · Dec 16, 2015
Accepting the Senate's changes (two-thirds required) — Passed. Vote details
Speaker of the House: Paul D. Ryan